1. Incidence of agranulocytosis with mianserin

   Newsletter Article 10 February 2013 Pages: 2 - 2

2. Systemic side effects associated with ophthalmic use of timolol

   Newsletter Article 10 February 2013 Pages: 2 - 2

3. Prevention of serious adverse reactions during anaesthesia

   Newsletter Article 10 February 2013 Pages: 2 - 3

4. Quinine overdosage

   Newsletter Article 10 February 2013 Pages: 3 - 3

5. Small risk of hospitalisation with phenylpropanolamine-related disorders

   Newsletter Article 10 February 2013 Pages: 3 - 3

6. Cardiac effects monitored during therapy with sodium stibogluconate

   Newsletter Article 10 February 2013 Pages: 3 - 4

7. Comments on piroxicam-induced peptic ulceration

   Newsletter Article 10 February 2013 Pages: 4 - 4

8. Acebutolol

   Newsletter Article 10 February 2013 Pages: 4 - 4

9. Ajmaline

   Newsletter Article 10 February 2013 Pages: 5 - 5

10. Anticonvulsants*

    Newsletter Article 10 February 2013 Pages: 5 - 5

11. Anti-inflammatory drugs

    Newsletter Article 10 February 2013 Pages: 5 - 5

12. Aspartame*

    Newsletter Article 10 February 2013 Pages: 5 - 5

13. Atenolol

    Newsletter Article 10 February 2013 Pages: 5 - 5

14. Beclomethasone dipropionate*

    Newsletter Article 10 February 2013 Pages: 5 - 6

15. Carbamazepine

    Newsletter Article 10 February 2013 Pages: 6 - 6

16. Ceftriaxone

    Newsletter Article 10 February 2013 Pages: 6 - 6

17. Chlorpropamide and Tolazamide*

    Newsletter Article 10 February 2013 Pages: 6 - 6

18. Disopyramide

    Newsletter Article 10 February 2013 Pages: 6 - 6

19. Dothiepin

    Newsletter Article 10 February 2013 Pages: 6 - 7

20. Doxycycline

    Newsletter Article 10 February 2013 Pages: 7 - 7

21. Ifosphamide/mesna

    Newsletter Article 10 February 2013 Pages: 7 - 7

22. Lithium

    Newsletter Article 10 February 2013 Pages: 7 - 7

23. Lithium overdose

    Newsletter Article 10 February 2013 Pages: 7 - 7

24. Mesna see Ifosphamide

    Newsletter Article 10 February 2013 Pages: 7 - 7

25. Metoclopramide

    Newsletter Article 10 February 2013 Pages: 7 - 8

26. Morphine

    Newsletter Article 10 February 2013 Pages: 8 - 8

27. Nomifensine*

    Newsletter Article 10 February 2013 Pages: 8 - 8

28. Penicillamine

    Newsletter Article 10 February 2013 Pages: 8 - 8

29. Prazosin

    Newsletter Article 10 February 2013 Pages: 8 - 8

30. Procainamide

    Newsletter Article 10 February 2013 Pages: 8 - 8

31. Procainamide metabolite

    Newsletter Article 10 February 2013 Pages: 8 - 9

32. Sulphasalazine

    Newsletter Article 10 February 2013 Pages: 9 - 9

33. Theophylline overdose

    Newsletter Article 10 February 2013 Pages: 9 - 9

34. Urokinase and streptokinase

    Newsletter Article 10 February 2013 Pages: 9 - 10

35. Vincristine

    Newsletter Article 10 February 2013 Pages: 10 - 10

36. Drug-induced skin reactions

    Newsletter Article 10 February 2013 Pages: 10 - 11

37. The side effects of terfenadine

    Newsletter Article 10 February 2013 Pages: 11 - 12

38. Systemic side effects of ophthalmic timolol

    Newsletter Article 10 February 2013 Pages: 12 - 12